Clinical Research

The future of healthcare, in your hands.

In close partnership with Javara Research, we offer clinical trials for a range of health issues and conditions, including COVID-19. Join us in these important studies. With your help, we will find solutions to our most pressing medical challenges, and ensure that healthcare is working effectively and equitably for all.

To participate in one of these trials, call 704-586-9386 or email [email protected].

Transportation to and from clinical research visits can be arranged at no cost. To stay updated on the latest news about clinical trials, sign up for Tryon Medical Partners’ email newsletter.

Clinical trials coming soon. Contact us for more information:
  • Celiac Disease
  • High Blood Pressure
  • Heartburn and Reflux
Currently enrolling trials:

Asthma

You may qualify to participate if you are 18 years or older and are initiating treatment with DUPIXENT. The study will require multiple clinical study visits and qualified participants will be compensated for your time.

COPD
You may qualify to participate if you are between 40 and 85 years of age, are a current smoker or have a history of smoking and have worsening of COPD symptoms that have required hospitalization or antibiotics and steroids within the past year while on stable inhaled medication. The study will require multiple clinical study visits and qualified participants will be compensated for your time.

Colon Cancer Screening
You may qualify to participate if you are 40 years or older. You must show zero symptoms or signs that require immediate, or near term, referral for diagnostic or therapeutic colonoscopy. Qualified participants will be compensated for your time. 

Crohn’s Disease
You may qualify to participate if you are 18 to 80 years of age, have moderate to severe active CD, Inadequate response, loss of response, or intolerance to a conventional or biologic treatment. Qualified participants will be compensated for your time. 

Eosinophilic Gastritis and/or Eosinophilic Duodenitis
You may qualify to participate if you are 18 to 65 years of age. This trial is for patients with active Eosinophilic Esophagitis and/or Eosinophilic Gastroenteritis and will test the efficacy of the study drug in reducing symptoms related to active Eosinophilic Esophagitis and/or Eosinophilic Gastroenteritis. The study will require multiple clinical study visits and qualified participants will be compensated for your time.

Gastroparesis
You may qualify to participate if you are 18 and older and suffer from gastroparesis (delayed stomach emptying). If you volunteer and qualify for the study, your participation could last up to 20 weeks (including the Screening and Follow-up Periods) and qualified participants will be compensated for your time.

Heart Condition
You may qualify if you are 70 years of age and older and do not have a history of Atrial Fibrillation or implantable cardiac device.  You must have Medicare health insurance (Part A & Part B (Medicare Fee-for-service)).  This study is to determine if an early detection mechanism for atrial fibrillation will reduce the risk of stroke. Qualified participants will be compensated for your time.

Hereditary Hemochromatosis Clinical Trial
Patients are needed to volunteer in a clinical trial for hemochromatosis. You may be eligible to participate if you are between 18 and 80 years of age and have been previously diagnosed with hemochromatosis. The study will require up to eight clinic visits and you will be compensated for your time.

Irritable Bowel Disease
You may qualify to participate if you are 18 years of age or older with a diagnosis of Crohn’s disease or Ulcerative colitis; using specific drugs to treat IBD and willing to provide additional study required information. Qualified participants will be compensated for your time.

Ulcerative Colitis
You may qualify for this study if you are a male or female aged 18 to 75 years old and are currently showing signs of moderate to severe active Ulcerative Colitis. Should you qualify for participation, you will be in the study for approximately 21 weeks including up to 7 clinic visits during the screening, treatment, and follow-up phases. Qualified participants will be compensated for your time. 

To participate in one of these upcoming trials, please call 704-586-9386 or [email protected].

To stay updated on the latest news about clinical trials, sign up for Tryon Medical Partners’ email newsletter.